Oklahoma AG sues drug companies and PBMs for inflating insulin prices, causing financial hardship for Type 1 Diabetes patients.

Oklahoma Attorney General Gentner Drummond sues drug companies and prescription benefit managers, accusing them of unlawfully inflating insulin prices, which have skyrocketed in the past decades. Insulin is a life necessity for Type 1 Diabetes patients, and the lawsuit claims that this price manipulation causes financial hardship for many families. The lawsuit alleges that the cost of production for insulin is significantly lower than the current retail prices, which range from $300 to $700 without insurance.

May 14, 2024
8 Articles

Further Reading